Hypertrophic Chronic Pachymeningitis as a Localized Immune Process in the Craniocervical Region
Neurol 56:107-109, Boller,B.,et al, 2001
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
Methotrexate Dist. in CSF after IV, Ventricular & Lumbar Inject
NEJM 293:161, Shapiro,W.R.,et al, 1975
A 59-Year-Old Woman Presenting with Diplopia, Dysarthria, Right-sided Weakness, and Encephalopathy
Neurol 97:e859-e864, Manzano, G.S.,et al, 2021
Clinicopathologic Conference, Granulomatosis with Polyangiitis
NEJM 379:2452-2461, Case 39-2018, 2018
Polymyalgia Rheumatica and Giant Cell Arteritis
JAMA 315:2442-2458, Buttgereit, F.,et al, 2016
MATILDE Chemotherapy Regimen for Primary CNS Lymphoma
Neurol 82:1370-1373, Ferreri, A.J.M.,et al, 2014
Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013
Juvenile Dermatomyositis and Other Idiopathic Inflammatory Myopathies of Childhood
Lancet 371:2201-2212, Feldman,B.M.,et al., 2008
Clinical Manifestations and Treatment of Rheumatoid Pachymeningitis
Neurol 68:1079-1080, Starosta,M.A. &Brandwein,S.R., 2007
Salvage Whole Brain Radiotherapy for Recurrent or Refractory Primary CNS Lymphoma
Neurol 69:1178-1182, Hottinger,A.F.,et al, 2007
Clinicopath Conf., Primary Diffuse Large-B-Cell Lymphoma of the Brain
NEJM 352:185-194, Case 1-2005, 2005
NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005
Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005
Treatment of Primary CNS Lymphoma with Methotrexate and Deferred Radiotherapy: A Report of NABTT 96-07
J Clin Oncol 21:1044-1049, Batchelor,T.,et al, 2003
German Cancer Society Neuro-Oncology Working Group NOA-03 Multicenter Trial of Single-Agent High-Dose Methotrexate for Primary Central Nervous System Lymphoma
Ann Neurol 51:247-252, Herrlinger,U.,et al, 2002
A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002
Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997
Therapy of Primary CNS Lymphoma with Methotrexate-Based Chemotherapy and Deferred Radiotherapy:Prelimary Results
Neurol 46:1757-1759, Cher,L.,et al, 1996
Drug Therapy of Idiopathic Inflammatory Myopathies:Response to Prednisone Azathioprine, & Methotrexate
Am J Med 94:379-387, Joffe,M.M.,et al, 1993
The Treatment of Inclusion Body Myositis:A Retrospective Review & Random, Prospective Trial of Immunosupp Therapy
Medicine 72:225-235, Leff,R.L.,et al, 1993
Stroke-Like Syndrome, Mineralizing Microangiopathy, and Neuroaxonal Dyst with Intrathecal Methotrexate
Neurol 41:1847-1848, Phanthumchinda,K.,et al, 1991
Central Nervous System Metastases from Non-Hodgkin's Lymphoma:Treatment & Prophylaxis
Am J Med 84:425-435, Recht,L.,et al, 1988
Immunosppressive Agents in Corticosteroid-Refractory Childhood Dermatomyositis
Neurol 30:286-291, Niakan,E.,et al, 1980
Cerebral Reticulum Cell Sarcoma
Arch Neurol 36:727, DeCoul,A.A.W.,et al, 1979
Central Nervous System Lesions in Childhood Leukemia
Neurol 28:678, Crosley,C.J.,et al, 1978
Polymyositis & Dermatomyositis
NEJM 292:344, 1975, 292:403975., Bohan,A.,et al, 1975